Research and Development Areas
Diabetes is a growing global health challenge. Our R&D team is at the forefront of discovering new ways to manage and treat diabetes. Our research is focused on understanding the underlying mechanisms of the disease and creating targeted therapies that offer better control and potentially transformative outcomes for patients.
Built upon a foundation grounded in scientific evidence,
SINGAPORE SCIENCES is recognized as the leader in the field of novel healthcare research & product developments.
Each year SINGAPORE SCIENCES sponsors numerous research projects in leading institutes in Singapore and internationally on cutting edge research, including double-blind, placebo-controlled studies proving the safety and efficacy of its premier products.
Diabetes
Diabetes is a growing global health challenge.
Our research is focused on understanding the underlying mechanisms of the disease and creating targeted therapies that offer better control and potentially transformative outcomes for patients.
ESG-MTI Funded Diabetes Projects
Our diabetes-focused projects, funded by the ESG-MTI, are at the forefront of addressing one of the most prevalent chronic diseases in the world.
Oncology
B.Eng (Bioengineering), Chartered Engineer, CEng (UK)
Cancer remains one of the most challenging diseases of our time.
Our oncology research is dedicated to uncovering new insights into cancer biology, developing targeted therapies, and finding better diagnostic tools. We are committed to making significant strides in cancer treatment and prevention.
Our team of scientists is exploring novel formulations and delivery methods that could potentially slow down or reverse the progression of cataracts, offering a more accessible and less invasive solution for patients.
Immunology
Our research in immunology aims to understand and harness the body's immune system to fight chronic diseases.
We are exploring novel therapies that can modulate immune responses, targeting conditions that have eluded effective treatment for too long.
Cataract
B.Eng (Bioengineering), Chartered Engineer, CEng (UK)
In addition to our work in diabetes, we are actively engaged in cutting-edge research on cataract eye drops.
Cataracts are a leading cause of blindness globally, and our research aims to develop a non-surgical treatment option that could revolutionize the way cataracts are managed.
Some studies indicate that cataracts are three to four times more prevalent in patients with diabetes under the age of 65.
Lipid and Endocrine Practice
Consultant Physician & Endocrinologist
MBBA, MMed (Int Med), FAMS (S'pore), PhD (Glasgow)
SINGAPORE SCIENCES is
headquartered in Singapore, Asia's Healthcare Hub.
SINGAPORE SCIENCES is a biopharmaceutical company that develops research-based, clinically tested healthcare products that addresses chronic diseases. Our portfolio and pipeline spanning endocrinology (diabetes), immunology and oncology, our goal is to use the most innovative approach in developing therapeutic products of the highest quality, to change the way how diseases such as diabetes, immune deficiencies and cancer are prevented and treated.
Our Research Areas
Lorem ipsum dolor sit amet, consectetur adipiscing elit pellentesque lectus.
Featured Products
Lorem ipsum dolor sit amet, consectetur adipiscing elit pellentesque lectus.
Shop
Lorem ipsum dolor sit amet, consectetur adipiscing elit pellentesque lectus.
